Evidence map›Paper›PMID 39236340›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Molecularly Imprinted Polymer Sensor Empowered by Bound States in the Continuum for Selective Trace-Detection of TGF-beta.

Gianluigi Zito, Giulia Siciliano, Aida Seifalinezhad, Bruno Miranda, Vittorino Lanzio, Adam Schwartzberg, Giuseppe Gigli, Antonio Turco, Ivo Rendina, Vito Mocella and 2 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Gianluigi ZitoInstitute of Applied Sciences and Intelligent Systems, National Research Council, Via Pietro Castellino 111, Napoli, 80131, Italy.ORCID 0000-0003-2376-0080
Giulia SicilianoInstitute of Nanotechnology, National Research Council, c/o Campus Ecotekne, Via Monteroni, Lecce, 73100, Italy.
Aida SeifalinezhadInstitute of Applied Sciences and Intelligent Systems, National Research Council, Via Pietro Castellino 111, Napoli, 80131, Italy.
Bruno MirandaInstitute of Applied Sciences and Intelligent Systems, National Research Council, Via Pietro Castellino 111, Napoli, 80131, Italy.
Vittorino LanzioMolecular Foundry, Lawrence Berkeley National Laboratory, 1 Cyclotron Rd, Berkeley, CA, 94720, USA.
Adam SchwartzbergMolecular Foundry, Lawrence Berkeley National Laboratory, 1 Cyclotron Rd, Berkeley, CA, 94720, USA.
Giuseppe GigliInstitute of Nanotechnology, National Research Council, c/o Campus Ecotekne, Via Monteroni, Lecce, 73100, Italy.
Antonio TurcoInstitute of Nanotechnology, National Research Council, c/o Campus Ecotekne, Via Monteroni, Lecce, 73100, Italy.
Ivo RendinaInstitute of Applied Sciences and Intelligent Systems, National Research Council, Via Pietro Castellino 111, Napoli, 80131, Italy.
Vito MocellaInstitute of Applied Sciences and Intelligent Systems, National Research Council, Via Pietro Castellino 111, Napoli, 80131, Italy.
Elisabetta PrimiceriInstitute of Nanotechnology, National Research Council, c/o Campus Ecotekne, Via Monteroni, Lecce, 73100, Italy.
Silvia RomanoInstitute of Applied Sciences and Intelligent Systems, National Research Council, Via Pietro Castellino 111, Napoli, 80131, Italy.

Funding

B-PLAS PRIN-2022TXWE32EU Italian National Recovery and Resilience Plan (NRRP) of NextGenerationEU PE0000023-NQSTIPRIN project INSPIRE P2022LETN5U.S. Department of Energy under No. DE-AC02-05CH11231
6 · The paper itself

Abstract

The integration of advanced materials and photonic nanostructures can lead to enhanced biodetection capabilities, crucial in clinical scenarios and point-of-care diagnostics, where simplified strategies are essential. Herein, a molecularly imprinted polymer (MIP) photonic nanostructure is demonstrated, which selectively binding to transforming growth factor-beta (TGF-β), in which the sensing transduction is enhanced by bound states in the continuum (BICs). The MIP operating as a synthetic antibody matrix and coupled with BIC resonance, enhances the optical response to TGF-β at imprinted sites, leading to an augmented detection capability, thoroughly evaluated through spectral shift and optical lever analogue readout. The validation underscores the MIP-BIC sensor capability to detect TGF-β in spiked saliva, achieving a limit of detection of 10 fM and a resolution of 0.5 pM at physiological concentrations, with a precision of two orders of magnitude above discrimination threshold in patients. The MIP tailored selectivity is highlighted by an imprinting factor of 52, showcasing the sensor resistance to interference from other analytes. The MIP-BIC sensor architecture streamlines the detection process eliminating the need for complex sandwich immunoassays and demonstrates the potential for high-precision quantification. This positions the system as a robust tool for biomarker detection, especially in real-world diagnostic scenarios.

Indexed as

Biosensing TechniquesMolecularly Imprinted PolymersTransforming Growth Factor betaHumansMolecular ImprintingNanostructuresPolymersSalivaMolecularly Imprinted PolymersPolymersTransforming Growth Factor betabiosensingbound states in the continuumcytokinemolecularly imprinted polymer

Identifiers

PMID39236340
PMCPMC11538715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.